Spire Healthcare Group PLC Heads of Terms signed with the NHS in Wales (9281I)
06 April 2020 - 10:08PM
UK Regulatory
TIDMSPI
RNS Number : 9281I
Spire Healthcare Group PLC
06 April 2020
Spire Healthcare Group plc
("Spire Healthcare", "the Company" or "the Group")
Heads of Terms signed with the NHS in Wales to provide COVID-19
support
6 April 2020
Spire Healthcare (LSE: SPI), a leading UK independent hospital
group, can confirm it has signed Heads of Terms with the Welsh
Health Specialised Services Committee to make its facilities and
services available to the NHS and its patients during the COVID-19
outbreak. This agreement, which commences on Monday 6 April, has
similar terms to that signed with NHS England (announced on 21
March) with payment weekly in advance, cost recovery and a one
month notice period on a rolling basis. The agreement means Spire
Healthcare's two hospitals in Wales join the 35 in England
assisting the NHS.
We are committed to supporting the NHS in combatting the
COVID-19 outbreak and will update the market when further
information is available.
For further information please contact:
Spire Healthcare
Cora McCallum, Head of Investor Relations +44 (0)7967 109 731
Instinctif Partners
Damian Reece +44 (0)7931 598 593
Guy Scarborough +44 (0)7917 178 920
Jeremy Durrant +44 (0)7792 918 648
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the
United Kingdom, with 39 private hospitals and 8 clinics across
England, Wales and Scotland.
Working in partnership with around 7,300 experienced
consultants, Spire Healthcare delivered tailored, personalised care
to approximately 810,000 in-patients and daycase patients in 2019,
and is the leading private provider, by volume, of knee and hip
operations in the United Kingdom.
The Group's well located and scalable hospitals have delivered
successful and award-winning clinical outcomes, positioning the
Group well with patients, consultants, the NHS, GPs and Private
Medical Insurance ("PMI") providers. 85% of Spire Healthcare's
hospitals are rated 'Good' or 'Outstanding' by the CQC (or the
equivalent in Scotland and Wales).
Spire Healthcare treats patients through a variety of routes
including PMI, Self-pay and the NHS, providing the Group with
diversified access to the expected growth opportunities in the UK
healthcare market, which faces significant supply challenges as a
result of NHS budget constraints and increasing demand from a
growing population with longer life expectancy.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCSSWFEMESSESL
(END) Dow Jones Newswires
April 06, 2020 08:08 ET (12:08 GMT)
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From Apr 2024 to May 2024
Spire Healthcare (LSE:SPI)
Historical Stock Chart
From May 2023 to May 2024